Test Price
190 AED✅ Home Collection Available
Immunohistochemistry Progesterone Receptor (PR) Test in UAE | 190 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval for archival FFPE blocks or tumor tissue in formalin.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by DHA-certified specialists.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Immunohistochemistry Progesterone Receptor (PR) Test specifically detects progesterone receptor protein in tumor tissue using advanced immunohistochemistry (IHC) staining, crucial for predicting hormonal therapy response in breast cancer. At our ISO-accredited lab, results are available within 5–7 business days, enabling timely, personalized treatment planning. This assay is performed exclusively on archival tissue specimens submitted as formalin-fixed paraffin-embedded (FFPE) blocks or tumor tissue in 10% neutral buffered formalin.
| Feature | Our PR IHC Test | Standard Hospital Lab |
|---|---|---|
| Methodology | Automated IHC with precise quantitation (Allred / H-score) | Manual IHC interpretation |
| Turnaround Time | 5–7 business days | 7–10 business days |
| Price | 190 AED | 250+ AED |
| Specimen Logistics | ✅ Secure Medical Courier Solid Tissue Retrieval | ❌ Not available |
| Accreditation | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | Basic lab license |
Physician Insight & Safety Protocols
Mr. Prabhakar Reddy Kalathoor | Specialist Diagnostic Radiology | DHA Registration ID: 61713011: Clinical correlation with patient history and other biomarkers is essential; this test alone does not dictate therapy. I encourage all patients to discuss results with their oncologist before making any treatment changes. Our laboratory adheres to the highest quality standards to deliver reliable results.
Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. Abrupt cessation of hormonal therapy may lead to disease progression or adverse outcomes.
Safety Exclusion Criteria & Red Flags
- Exclusion: Patients with severe coagulation disorders or inaccessible tumor tissue may not be suitable for biopsy-based sampling. Hospital extraction only – sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Red Flag: If you experience severe pain, excessive bleeding, or signs of infection (fever, redness, pus) at the biopsy site after collection, seek emergency medical attention immediately.
Patient FAQ & Clinical Guidance
1. What is the Immunohistochemistry Progesterone Receptor (PR) Test used for?
This immunohistochemistry test identifies progesterone receptor protein expression in tumor tissue to guide hormonal therapy. It determines whether breast cancer cells are likely to respond to endocrine treatments such as tamoxifen or aromatase inhibitors. The result is interpreted by an oncologist or surgical pathologist alongside ER and HER2 status to formulate a comprehensive treatment plan.
2. Why do I need to provide a histopathology report along with the biopsy sample?
Providing the histopathology report correlates IHC findings with original tumor morphology, ensuring precise diagnostic interpretation. The report contains critical details about tumor type, grade, and initial diagnosis that our pathologists use to validate immunohistochemistry results and avoid misclassification. This practice aligns with international standards for diagnostic accuracy and patient safety as outlined in Federal Decree-Law No. 4 of 2016 on Medical Liability.
3. What does it mean if my Progesterone Receptor (PR) is negative?
A negative result means no progesterone receptors are detected, implying likely resistance to hormonal therapy. In breast cancer, PR-negative tumors generally do not benefit from endocrine treatments that block progesterone signaling. However, your oncologist will combine this information with estrogen receptor (ER) and HER2 status to determine the most effective therapy, which may include chemotherapy or targeted agents. Never alter your treatment without professional consultation.
4. How is the sample collected for this test?
Sample collection requires a hospital-based biopsy or surgical excision performed by a qualified physician. The extracted tumor tissue is placed in 10% neutral buffered formalin or processed into an FFPE block at the hospital pathology department. Our Secure Medical Courier Solid Tissue Specimen Retrieval service then transports the archival material to our laboratory under ambient conditions. Hospital extraction only – mobile home phlebotomy is disabled for safety.
5. How long does it take to get results, and how are they delivered?
Results are typically available within 5–7 business days from sample receipt at our ISO-accredited laboratory. You will receive a detailed digital report via email and secure patient portal, with a telephonic clinical guidance session scheduled to explain the findings and next steps. Hard copies can be couriered upon request.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Security: All patient data is processed in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your medical records, test results, and personal identifiers are encrypted, access-controlled, and never shared without explicit consent.
Clinical Safety: Diagnostic procedures and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring all tissue handling, IHC processing, and result reporting meet the highest standards of medical accountability.
Accreditation: ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). DHA Facility License No. 1143. All laboratory practices follow DHA and MOHAP standard nomenclature for pathology and immunohistochemistry.
Clinical & Logistical Metadata
| Test Name | Immunohistochemistry Progesterone Receptor (PR) Test |
| Price (AED) | 190 AED |
| Turnaround Time | 5–7 business days |
| Sample Type / Matrix | Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block / Tumor Tissue in 10% Neutral Buffered Formalin |
| Methodology Used | Automated Immunohistochemistry (IHC) with Allred / H-Score Quantitation |
| ICD-10-CM Code | C50.919, Z17.1, Z15.01 |
| LOINC Code | 18499-5 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians